Gonococcal porin vaccine evaluation: comparison of Por proteosomes, liposomes, and blebs isolated from rmp deletion mutants
- PMID: 1323620
- DOI: 10.1093/infdis/166.3.551
Gonococcal porin vaccine evaluation: comparison of Por proteosomes, liposomes, and blebs isolated from rmp deletion mutants
Abstract
The gonococcal major outer membrane protein, Por (protein I), is a potential vaccine candidate. A large-scale animal trial compared the immunogenicity of Por inserted in liposomes (mimicking its in vivo structure) with previously used vaccines containing Por. Por was purified from Rmp (protein III)-negative gonococcal mutants and made into five different formulations: proteosomes, proteosomes absorbed to alum, liposomes, gonococcal membrane blebs, and gonococcal membrane blebs absorbed to alum. Por liposomes induced the greatest amount of Por antibodies; proteosomes and both preparations of blebs induced minimal amounts of Por antibodies. Proteosomes absorbed to alum induced slightly lower amounts of Por antibodies than did liposomes, especially when protein IA was used. Whole-organism absorption studies revealed that a significantly greater percentage of liposome-induced Por antibodies recognized exposed portions of the protein than did proteosome- or proteosome/alum-induced antibodies.
Similar articles
-
Characterization and specificity of antibodies to protein I of Neisseria gonorrhoeae produced by injection with various protein I-adjuvant preparations.J Exp Med. 1988 Nov 1;168(5):1883-97. doi: 10.1084/jem.168.5.1883. J Exp Med. 1988. PMID: 3141555 Free PMC article.
-
Protein I (Por) of Neisseria gonorrhoeae as an immunogen: liposomes, proteosomes, and the lack of blocking antibodies.Trans Assoc Am Physicians. 1989;102:78-90. Trans Assoc Am Physicians. 1989. PMID: 2561644 No abstract available.
-
GD3/proteosome vaccines induce consistent IgM antibodies against the ganglioside GD3.Vaccine. 1993 Sep;11(12):1199-204. doi: 10.1016/0264-410x(93)90043-w. Vaccine. 1993. PMID: 8256501
-
Developing a gonococcal protein I vaccine.Adv Exp Med Biol. 1989;251:315-27. doi: 10.1007/978-1-4757-2046-4_28. Adv Exp Med Biol. 1989. PMID: 2514585 Review. No abstract available.
-
[Gonococcal surface antigens and their significance for serotyping and vaccines].Hautarzt. 1985 Jun;36(6):320-5. Hautarzt. 1985. PMID: 2862130 Review. German.
Cited by
-
Immunization with the recombinant PorB outer membrane protein induces a bactericidal immune response against Neisseria meningitidis.Infect Immun. 2002 Aug;70(8):4028-34. doi: 10.1128/IAI.70.8.4028-4034.2002. Infect Immun. 2002. PMID: 12117908 Free PMC article.
-
The Neisseria meningitidis macrophage infectivity potentiator protein induces cross-strain serum bactericidal activity and is a potential serogroup B vaccine candidate.Infect Immun. 2011 Sep;79(9):3784-91. doi: 10.1128/IAI.05019-11. Epub 2011 Jun 27. Infect Immun. 2011. PMID: 21708989 Free PMC article.
-
Identification of regulatory elements that control expression of the tbpBA operon in Neisseria gonorrhoeae.J Bacteriol. 2014 Aug;196(15):2762-74. doi: 10.1128/JB.01693-14. Epub 2014 May 16. J Bacteriol. 2014. PMID: 24837286 Free PMC article.
-
Neisseria meningitidis lipopolysaccharide modulates the specific humoral immune response to neisserial porins but has no effect on porin-induced upregulation of costimulatory ligand B7-2.Infect Immun. 2001 Aug;69(8):5031-6. doi: 10.1128/IAI.69.8.5031-5036.2001. Infect Immun. 2001. PMID: 11447183 Free PMC article.
-
Gonococcal invasion of epithelial cells driven by P.IA, a bacterial ion channel with GTP binding properties.J Exp Med. 1998 Sep 7;188(5):941-52. doi: 10.1084/jem.188.5.941. J Exp Med. 1998. PMID: 9730895 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources